In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats.
paper
Cited
Public
Unavailable
- Authors
- Richter, R M; Weiss, F
- Year
- 1999
- Journal
- Synapse (New York, N.Y.)
- PMID
- 10332801
- DOI
- 10.1002/(SICI)1098-2396(19990615)32:4<254::AID-SYN2>3.0.CO;2-H
Previous studies have suggested a role for corticotropin-releasing factor (CRF) in the central nucleus of the amygdala (CeA) in the aversive and anxiogenic effects of withdrawal from opiates and ethanol. To test whether this role of CRF extends to cocaine withdrawal as well, the release of CRF in rat amygdala was monitored by intracranial microdialysis during a 12-hour session of intravenous cocaine self-administration and subsequent 12-hour cocaine withdrawal period. Cocaine self-administration tended to lower dialysate CRF concentrations to approximately 75% of CRF levels in controls. In contrast, subsequent cocaine withdrawal produced a profound increase in CRF release, which reached peak levels of approximately 400% of baseline between 11 and 12 hours post-cocaine. These results provide evidence that cocaine withdrawal activates CRF neurons in the amygdala, a site that has been implicated in emotional and anxiogenic effects of stress and drug withdrawal syndromes.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Neurocircuitry underlying the actions of glucagon-like peptide 1 and peptide YY<sub>3</sub><sub>-</sub><sub>36</sub> in the suppression of food, drug-seeking, and anxiogenesis. | Dumiaty Y et al. | β | 2024 | β |
| Teneurin C-terminal associated peptide (TCAP)-1 attenuates the development and expression of naloxone-precipitated morphine withdrawal in male Swiss Webster mice. | Mueller LE et al. | β | 2024 | β |
| A mechanistic overview of approaches for the treatment of psychostimulant dependence. | Jensen KL et al. | β | 2022 | β |
| Serum Corticotrophin Releasing Factor (CRF) and its correlation with stress and craving in detoxified opioid-dependent subjects. | Chatterjee B et al. | β | 2022 | β |
| Consideration of sex as a biological variable in the translation of pharmacotherapy for stress-associated drug seeking. | Martin EL et al. | β | 2021 | β |
| Converging vulnerability factors for compulsive food and drug use. | Serafine KM et al. | β | 2021 | β |
| Fragility of reward vs antifragility of defense brain systems in drug dependence. | Prospero-Garcia OE et al. | β | 2021 | β |
| Regulation of CRF mRNA in the Rat Extended Amygdala Following Chronic Cocaine: Sex Differences and Effect of Delta Opioid Receptor Agonism. | Connelly KL et al. | β | 2020 | β |
| Multigenerational and transgenerational effects of paternal exposure to drugs of abuse on behavioral and neural function. | Goldberg LR et al. | β | 2019 | β |
| Pituitary Adenylate Cyclase-Activating Peptide (PACAP) Signaling and the Dark Side of Addiction. | Miles OW et al. | β | 2019 | β |
| The neurobiology of addiction. | Uhl GR et al. | β | 2019 | β |
| Acupuncture on the Stress-Related Drug Relapse to Seeking. | Roh HS et al. | β | 2018 | β |
| Aqueous Extract of Semen <i>Ziziphi Spinosae</i> Exerts Anxiolytic Effects during Nicotine Withdrawal via Improvement of Amygdaloid CRF/CRF1R Signaling. | Gu C et al. | β | 2018 | β |
| Corticotropin-releasing factor receptor 2-deficiency eliminates social behaviour deficits and vulnerability induced by cocaine. | Morisot N et al. | β | 2018 | β |
| Median and Dorsal Raphe Serotonergic Neurons Control Moderate Versus Compulsive Cocaine Intake. | Verheij MMM et al. | β | 2018 | β |
| Negative consequences of early-life adversity on substance use as mediated by corticotropin-releasing factor modulation of serotonin activity. | Forster GL et al. | β | 2018 | β |
| Corticotropin-Releasing Factor (CRF) and Addictive Behaviors. | Roberto M et al. | β | 2017 | β |
| Individual differences in the neuropsychopathology of addiction. | George O et al. | β | 2017 | β |
| CRF-like receptor SEB-3 in sex-common interneurons potentiates stress handling and reproductive drive in C. elegans. | Jee C et al. | β | 2016 | β |
| Emerging targets for addiction neuropharmacology: From mechanisms to therapeutics. | Ubaldi M et al. | β | 2016 | β |
| Substance use modulates stress reactivity: Behavioral and physiological outcomes. | Fosnocht AQ et al. | β | 2016 | β |
| Corticotropin releasing factor: a key role in the neurobiology of addiction. | Zorrilla EP et al. | β | 2014 | β |
| CRFβ receptor-deficiency reduces recognition memory deficits and vulnerability to stress induced by cocaine withdrawal. | Morisot N et al. | β | 2014 | β |
| Drug withdrawal conceptualized as a stressor. | Chartoff EH et al. | β | 2014 | β |
| Neurobiological mechanisms underlying relapse to cocaine use: contributions of CRF and noradrenergic systems and regulation by glucocorticoids. | McReynolds JR et al. | β | 2014 | β |
| Sex differences in the neurobiology of drug addiction. | Bobzean SA et al. | β | 2014 | β |
| Adaptations in brain reward circuitry underlie palatable food cravings and anxiety induced by high-fat diet withdrawal. | Sharma S et al. | β | 2013 | β |
| Emerging role for corticotropin releasing factor signaling in the bed nucleus of the stria terminalis at the intersection of stress and reward. | Silberman Y et al. | β | 2013 | β |
| Inhibition of corticotropin releasing factor expression in the central nucleus of the amygdala attenuates stress-induced behavioral and endocrine responses. | Callahan LB et al. | β | 2013 | β |
| Preclinical studies on comorbidity between depression and psychostimulant addiction. | Filip M et al. | β | 2013 | β |
| The role of galanin system in modulating depression, anxiety, and addiction-like behaviors after chronic restraint stress. | Zhao X et al. | β | 2013 | β |
| Allostasis and addiction: role of the dopamine and corticotropin-releasing factor systems. | George O et al. | β | 2012 | β |
| Antagonism of cannabinoid 1 receptors reverses the anxiety-like behavior induced by central injections of corticotropin-releasing factor and cocaine withdrawal. | Kupferschmidt DA et al. | β | 2012 | β |
| CRF2 receptor-deficiency eliminates opiate withdrawal distress without impairing stress coping. | Ingallinesi M et al. | β | 2012 | β |
| Extended access cocaine self-administration differentially activates dorsal raphe and amygdala corticotropin-releasing factor systems in rats. | Zorrilla EP et al. | β | 2012 | β |
| Increases of CRF in the amygdala are responsible for reinstatement of methamphetamine-seeking behavior induced by footshock. | Nawata Y et al. | β | 2012 | β |
| Stress and addiction: contribution of the corticotropin releasing factor (CRF) system in neuroplasticity. | Haass-Koffler CL et al. | β | 2012 | β |
| The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction. | Burkett JP et al. | β | 2012 | β |
| Tobacco addiction and the dysregulation of brain stress systems. | Bruijnzeel AW | β | 2012 | β |
| Activation of brain NOP receptors attenuates acute and protracted alcohol withdrawal symptoms in the rat. | Economidou D et al. | β | 2011 | β |
| Adrenal activity during repeated long-access cocaine self-administration is required for later CRF-Induced and CRF-dependent stressor-induced reinstatement in rats. | Graf EN et al. | β | 2011 | β |
| AUTOMATED ANALYSIS OF QUANTITATIVE IMAGE DATA USING ISOMORPHIC FUNCTIONAL MIXED MODELS, WITH APPLICATION TO PROTEOMICS DATA. | Morris JS et al. | β | 2011 | β |
| Dissection of corticotropin-releasing factor system involvement in locomotor sensitivity to methamphetamine. | Giardino WJ et al. | β | 2011 | β |
| Effects of a selective Y2R antagonist, JNJ-31020028, on nicotine abstinence-related social anxiety-like behavior, neuropeptide Y and corticotropin releasing factor mRNA levels in the novelty-seeking phenotype. | Aydin C et al. | β | 2011 | β |
| Effects of lidocaine-induced inactivation of the bed nucleus of the stria terminalis, the central or the basolateral nucleus of the amygdala on the opponent-process actions of self-administered cocaine in rats. | Wenzel JM et al. | β | 2011 | β |
| Endocannabinoid regulation of acute and protracted nicotine withdrawal: effect of FAAH inhibition. | Cippitelli A et al. | β | 2011 | β |
| Intra-ventral tegmental area or intracerebroventricular orexin-A increases the intra-cranial self-stimulation threshold via activation of the corticotropin-releasing factor system in rats. | Hata T et al. | β | 2011 | β |
| Molecular signaling and translational significance of the corticotropin releasing factor system. | Ronan PJ et al. | β | 2011 | β |
| Ovarian hormones and propensity to drug relapse: a review. | Hudson A et al. | β | 2011 | β |
| Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention. | Logrip ML et al. | β | 2011 | β |
| The dark side of food addiction. | Parylak SL et al. | β | 2011 | β |
| Ξ²-Adrenergic receptors enhance excitatory transmission in the bed nucleus of the stria terminalis through a corticotrophin-releasing factor receptor-dependent and cocaine-regulated mechanism. | Nobis WP et al. | β | 2011 | β |
| Corticotropin releasing factor and neuroplasticity in cocaine addiction. | Corominas M et al. | β | 2010 | β |
| Corticotropin-releasing factor in the dorsal raphe nucleus: Linking stress coping and addiction. | Valentino RJ et al. | β | 2010 | β |
| Dopamine receptor mechanisms mediate corticotropin-releasing factor-induced long-term potentiation in the rat amygdala following cocaine withdrawal. | Krishnan B et al. | β | 2010 | β |
| Evaluation of the relationship between anxiety during withdrawal and stress-induced reinstatement of cocaine seeking. | Erb S | β | 2010 | β |
| Involvement of tissue plasminogen activator in stress responsivity during acute cocaine withdrawal in mice. | Zhou Y et al. | β | 2010 | β |
| Molecular and genetic substrates linking stress and addiction. | Briand LA et al. | β | 2010 | β |
| Neural substrates of psychostimulant withdrawal-induced anhedonia. | D'Souza MS et al. | β | 2010 | β |
| Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor. | Koob GF et al. | β | 2010 | β |
| Neurobiology of dysregulated motivational systems in drug addiction. | Edwards S et al. | β | 2010 | β |
| Neuroplastic alterations in the limbic system following cocaine or alcohol exposure. | Stuber GD et al. | β | 2010 | β |
| Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin. | Martin-Fardon R et al. | β | 2010 | β |
| Single-nucleotide polymorphisms in corticotropin releasing hormone receptor 1 gene (CRHR1) are associated with quantitative trait of event-related potential and alcohol dependence. | Chen AC et al. | β | 2010 | β |
| The role of CRF and CRF-related peptides in the dark side of addiction. | Koob GF | β | 2010 | β |
| Brain stress systems in the amygdala and addiction. | Koob GF | β | 2009 | β |
| Characterizing intercellular signaling peptides in drug addiction. | Romanova EV et al. | β | 2009 | β |
| Corticotropin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine withdrawal in rats. | Marcinkiewcz CA et al. | β | 2009 | β |
| CRF enhancement of GIRK channel-mediated transmission in dopamine neurons. | Beckstead MJ et al. | β | 2009 | β |
| Development of pharmacotherapies for drug addiction: a Rosetta stone approach. | Koob GF et al. | β | 2009 | β |
| Neurobiological substrates for the dark side of compulsivity in addiction. | Koob GF | β | 2009 | β |
| Stress, alcohol and drug interaction: an update of human research. | Uhart M et al. | β | 2009 | β |
| A neuropeptide-centric view of psychostimulant addiction. | Boutrel B | β | 2008 | β |
| A role for brain stress systems in addiction. | Koob GF | β | 2008 | β |
| Comparison of acute and chronic neurochemical effects of cocaine and cocaine cues in rhesus monkeys and rodents: focus on striatal and cortical dopamine systems. | Bradberry CW | β | 2008 | β |
| CRF(1) receptor antagonists attenuate escalated cocaine self-administration in rats. | Specio SE et al. | β | 2008 | β |
| Dopamine and corticotropin-releasing factor synergistically alter basolateral amygdala-to-medial prefrontal cortex synaptic transmission: functional switch after chronic cocaine administration. | Orozco-Cabal L et al. | β | 2008 | β |
| Effects of acute ethanol on opioid peptide release in the central amygdala: an in vivo microdialysis study. | Lam MP et al. | β | 2008 | β |
| Hedonic Homeostatic Dysregulation as a Driver of Drug-Seeking Behavior. | Koob GF | β | 2008 | β |
| Microdialysis and the neurochemistry of addiction. | Torregrossa MM et al. | β | 2008 | β |
| Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence. | Smith RJ et al. | β | 2008 | β |
| Stressor- and corticotropin releasing factor-induced reinstatement and active stress-related behavioral responses are augmented following long-access cocaine self-administration by rats. | Mantsch JR et al. | β | 2008 | β |
| The influence of stress on the transition from drug use to addiction. | Wand G | β | 2008 | β |
| Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats. | Bruijnzeel AW et al. | β | 2007 | β |
| Long-term potentiation (LTP) in the central amygdala (CeA) is enhanced after prolonged withdrawal from chronic cocaine and requires CRF1 receptors. | Fu Y et al. | β | 2007 | β |
| Neonatal amygdala lesions: co-occurring impact on social/fear-related behavior and cocaine sensitization in adult rats. | Chambers RA et al. | β | 2007 | β |
| Restraint-induced corticosterone secretion and hypothalamic CRH mRNA expression are augmented during acute withdrawal from chronic cocaine administration. | Mantsch JR et al. | β | 2007 | β |
| Synaptic plasticity and addiction. | Kauer JA et al. | β | 2007 | β |
| The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal. | Skelton KH et al. | β | 2007 | β |
| The CRF1 receptor antagonist, R121919, attenuates the severity of precipitated morphine withdrawal. | Skelton KH et al. | β | 2007 | β |
| Cocaine withdrawal enhances long-term potentiation induced by corticotropin-releasing factor at central amygdala glutamatergic synapses via CRF, NMDA receptors and PKA. | Pollandt S et al. | β | 2006 | β |
| Glucocorticoids, chronic stress, and obesity. | Dallman MF et al. | β | 2006 | β |
| Links between depression and substance abuse in adolescents: neurobiological mechanisms. | Rao U | β | 2006 | β |
| Regulation of synaptic transmission by CRF receptors. | Orozco-Cabal L et al. | β | 2006 | β |
| Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats. | Stinus L et al. | β | 2005 | β |
| Chronic ethanol ingestion modulates proanxiety factors expressed in rat central amygdala. | LΓ€ck AK et al. | β | 2005 | β |
| DHEAS and POMS measures identify cocaine dependence treatment outcome. | Wilkins JN et al. | β | 2005 | β |
| Psychostimulant withdrawal as an inducing condition in animal models of depression. | Barr AM et al. | β | 2005 | β |
| Stress enhancement of craving during sobriety: a risk for relapse. | Breese GR et al. | β | 2005 | β |
| The corticotropin-releasing factor (CRF)-system and monoaminergic afferents in the central amygdala: investigations in different mouse strains and comparison with the rat. | Asan E et al. | β | 2005 | β |
| The corticotropin-releasing factor receptor-1 pathway mediates the negative affective states of opiate withdrawal. | Contarino A et al. | β | 2005 | β |
| The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence. | Bruijnzeel AW et al. | β | 2005 | β |
| Agents in development for the management of cocaine abuse. | Gorelick DA et al. | β | 2004 | β |
| Effects of chronic cocaine exposure on corticotropin-releasing hormone binding protein in the central nucleus of the amygdala and bed nucleus of the stria terminalis. | Erb S et al. | β | 2004 | β |
| Immune cell activity during the initial stages of withdrawal from chronic exposure to cocaine or morphine. | Avila AH et al. | β | 2004 | β |
| Neurobiological mechanisms in addictive and psychiatric disorders. | Bruijnzeel AW et al. | β | 2004 | β |
| Neurobiological mechanisms in the transition from drug use to drug dependence. | Koob GF et al. | β | 2004 | β |
| Spontaneous withdrawal from the triazolobenzodiazepine alprazolam increases cortical corticotropin-releasing factor mRNA expression. | Skelton KH et al. | β | 2004 | β |
| Alcoholism: allostasis and beyond. | Koob GF | β | 2003 | β |
| Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal. | Zhou Y et al. | β | 2003 | β |
| Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence. | Valdez GR et al. | β | 2003 | β |
| Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data. | Tanda G et al. | β | 2003 | β |
| c-Fos and peptide immunoreactivities in the central extended amygdala of morphine-dependent rats after naloxone-precipitated withdrawal. | Veinante P et al. | β | 2003 | β |
| Corticotropin-releasing factor testing reveals a dose-dependent difference in methadone maintained vs control subjects. | Schluger JH et al. | β | 2003 | β |
| Differential involvement of amygdaloid CRH system(s) in the salience and valence of the stimuli. | Merali Z et al. | β | 2003 | β |
| Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes. | Lu L et al. | β | 2003 | β |
| Escalation of cocaine self-administration does not depend on altered cocaine-induced nucleus accumbens dopamine levels. | Ahmed SH et al. | β | 2003 | β |
| Increased CRH mRNA levels in the rat amygdala during short-term withdrawal from chronic 'binge' cocaine. | Zhou Y et al. | β | 2003 | β |
| Interrelations between monoaminergic afferents and corticotropin-releasing factor-immunoreactive neurons in the rat central amygdaloid nucleus: ultrastructural evidence for dopaminergic control of amygdaloid stress systems. | Eliava M et al. | β | 2003 | β |
| Morphine and cocaine influence on CRF biosynthesis in the rat central nucleus of amygdala. | Maj M et al. | β | 2003 | β |
| Neuroadaptive mechanisms of addiction: studies on the extended amygdala. | Koob GF | β | 2003 | β |
| Prepulse inhibition during withdrawal from an escalating dosage schedule of amphetamine. | Russig H et al. | β | 2003 | β |
| Prior, repeated exposure to cocaine potentiates locomotor responsivity to central injections of corticotropin-releasing factor (CRF) in rats. | Erb S et al. | β | 2003 | β |
| Stress-induced suppression of the immune system after withdrawal from chronic cocaine. | Avila AH et al. | β | 2003 | β |
| The reinstatement model of drug relapse: history, methodology and major findings. | Shaham Y et al. | β | 2003 | β |
| A 'crash' course on psychostimulant withdrawal as a model of depression. | Barr AM et al. | β | 2002 | β |
| CRHR1 Receptor binding and lipophilicity of pyrrolopyrimidines, potential nonpeptide corticotropin-releasing hormone type 1 receptor antagonists. | Hsin LW et al. | β | 2002 | β |
| Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. | Olive MF et al. | β | 2002 | β |
| Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. | Valdez GR et al. | β | 2002 | β |
| Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal. | McNally GP et al. | β | 2002 | β |
| Sigma(1) (sigma(1)) receptor antagonists represent a new strategy against cocaine addiction and toxicity. | Maurice T et al. | β | 2002 | β |
| Temporal concordance of cocaine effects on mood states and neuroendocrine hormones. | Mendelson JH et al. | β | 2002 | β |
| Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. | Weiss F et al. | β | 2001 | β |
| Drug addiction: functional neurotoxicity of the brain reward systems. | Weiss F et al. | β | 2001 | β |
| Iboga compounds reverse the behavioural disinhibiting and corticosterone effects of acute methamphetamine: Implications for their antiaddictive properties. | Szumlinski KK et al. | β | 2001 | β |
| Neurobiology of the nicotine withdrawal syndrome. | Kenny PJ et al. | β | 2001 | β |
| Recent research on alcohol tolerance and dependence. | Suwaki H et al. | β | 2001 | β |
| Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems. | Skelton KH et al. | β | 2000 | β |
| Neurobiology of addiction. Toward the development of new therapies. | Koob GF | β | 2000 | β |
| Stress-induced relapse to heroin and cocaine seeking in rats: a review. | Shaham Y et al. | β | 2000 | β |
| A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. | Koob GF et al. | β | 1999 | β |
| Stress, corticotropin-releasing factor, and drug addiction. | Koob GF | β | 1999 | β |
| Reinforcement processes in opiate addiction: a homeostatic model. | Schulteis G et al. | β | 1996 | β |